Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bladder Cancer

  Free Subscription


1 Apoptosis
1 Arch Pathol Lab Med
1 Asian J Urol
1 Asian Pac J Cancer Prev
2 BMC Cancer
1 BMC Urol
1 BMJ Case Rep
1 Clin Cancer Res
7 Clin Genitourin Cancer
1 Commun Biol
1 Comput Methods Programs Biomed
2 Curr Opin Urol
1 Epidemiology
2 Eur J Med Res
1 Eur Surg Res
7 Eur Urol
1 Front Chem
1 Front Immunol
4 Front Oncol
1 Front Surg
2 Hum Cell
1 Int J Urol
1 J Gastrointest Cancer
1 J Immunother Cancer
1 J Inflamm Res
1 J Oncol
1 Med Sci Monit
1 Med Sci Sports Exerc
1 Prog Urol
1 Protein Pept Lett
1 Rep Biochem Mol Biol
1 Sci Rep
1 Stem Cell Res Ther
1 Urol Oncol
1 Zhonghua Zhong Liu Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. WANG K, Wang G, Li G, Zhang W, et al
    m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
    Apoptosis. 2023 Jan 31. doi: 10.1007/s10495-023-01817.
    PubMed         Abstract available

    Arch Pathol Lab Med

  2. AVULOVA S, Benidir T, Cheville JC, Packiam VT, et al
    Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.
    Arch Pathol Lab Med. 2023;147:202-207.
    PubMed         Abstract available

    Asian J Urol

  3. CHALFANT V, Blute ML Jr, Silberstein P
    Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013.
    Asian J Urol. 2023;10:9-18.
    PubMed         Abstract available

    Asian Pac J Cancer Prev

  4. ABDEL-HAFIZ SM, Sherif H, Romeih M, Elesaily K, et al
    Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer.
    Asian Pac J Cancer Prev. 2023;24:121-131.
    PubMed         Abstract available

    BMC Cancer

  5. JUNG M, Rose M, Knuechel R, Loeffler C, et al
    Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
    BMC Cancer. 2023;23:113.
    PubMed         Abstract available

  6. HUANG W, Zhu L, Huang H, Li Y, et al
    IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
    BMC Cancer. 2023;23:116.
    PubMed         Abstract available

    BMC Urol

  7. WANG Z, Huang Z, Cao X, Zhang F, et al
    A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
    BMC Urol. 2023;23:10.
    PubMed         Abstract available

    BMJ Case Rep

  8. MORENO-FONTELA MP, Pinazo-Rubio I, Garrido-Abad P
    Penoscrotal oedema as the first sign of metastatic urothelial bladder cancer.
    BMJ Case Rep. 2023;16:e254106.

    Clin Cancer Res

  9. MISHRA A, Kumar D, Gupta K, Lofland G, et al
    Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics.
    Clin Cancer Res. 2023;29:581-591.
    PubMed         Abstract available

    Clin Genitourin Cancer

  10. ISHIHARA H, Ishiyama Y, Nemoto Y, Nakamura K, et al
    Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:136-145.
    PubMed         Abstract available

  11. UMEDA K, Tanaka N, Yasumizu Y, Takeda T, et al
    Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab.
    Clin Genitourin Cancer. 2023;21:128-135.
    PubMed         Abstract available

  12. LIN D, Luo S, Lin S, Zhong L, et al
    Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma-A Cost-Effectiveness Analysis.
    Clin Genitourin Cancer. 2023;21:8-15.
    PubMed         Abstract available

  13. LIN Y, Lin L, Yang Y, Li M, et al
    DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2023;21:32-42.
    PubMed         Abstract available

  14. CHAWLA NS, Sayegh N, Tripathi N, Govindarajan A, et al
    Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:69-75.
    PubMed         Abstract available

  15. TAHERI D, Jahanshahi F, Khajavi A, Kafi F, et al
    The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
    Clin Genitourin Cancer. 2023;21:84-90.
    PubMed         Abstract available

  16. MAKRAKIS D, Wright JL, Roudier MP, Garcia J, et al
    A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00261.
    PubMed         Abstract available

    Commun Biol

  17. MATHUR P, De Barros Santos C, Lachuer H, Patat J, et al
    Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that control lysosome positioning in the bladder cancer model.
    Commun Biol. 2023;6:114.
    PubMed         Abstract available

    Comput Methods Programs Biomed

  18. CHEONG JK, Ooi EH, Chiew YS, Menichetti L, et al
    Gold nanorods assisted photothermal therapy of bladder cancer in mice: A computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer.
    Comput Methods Programs Biomed. 2023;230:107363.
    PubMed         Abstract available

    Curr Opin Urol

  19. TONIN E, Shariat SF, Schiavina R, Brunocilla E, et al
    En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?
    Curr Opin Urol. 2023;33:147-151.
    PubMed         Abstract available

  20. WALZ S, Aslani V, Sawodny O, Stenzl A, et al
    Robotic radical cystectomy - more precision needed?
    Curr Opin Urol. 2023;33:157-162.
    PubMed         Abstract available


  21. GETZ K, Hubbard RA, Linn KA
    Performance of Multiple Imputation Using Modern Machine Learning Methods in Electronic Health Records Data.
    Epidemiology. 2023;34:206-215.
    PubMed         Abstract available

    Eur J Med Res

  22. LIU L, Li C, Wang Q, Yuan H, et al
    A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.
    Eur J Med Res. 2023;28:61.
    PubMed         Abstract available

  23. LI DX, Feng DC, Wang XM, Wu RC, et al
    M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients.
    Eur J Med Res. 2023;28:55.
    PubMed         Abstract available

    Eur Surg Res

  24. DARIANE C, Timsit MO
    DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Eur Surg Res. 2022;63:155-164.
    PubMed         Abstract available

    Eur Urol

  25. PEDERSEN GL, Erikson MS, Mogensen K, Rosthoj S, et al
    Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A P
    Eur Urol. 2023;83:125-130.
    PubMed         Abstract available

  26. ERLMEIER F, Klumper N, Landgraf L, Strissel PL, et al
    Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition.
    Eur Urol. 2023;83:133-142.
    PubMed         Abstract available

  27. BASILE G, Bandini M, Montorsi F, Necchi A, et al
    Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Foll
    Eur Urol. 2023 Jan 25:S0302-2838(23)00021-0. doi: 10.1016/j.eururo.2023.

  28. LINDGREN MS, Jensen JB
    Reply to Benjamin Pradere, Giuseppe Basile, and Thomas Seisen's Letter to the Editor re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjot, Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chem
    Eur Urol. 2023 Jan 27:S0302-2838(23)00023-4. doi: 10.1016/j.eururo.2023.

  29. HAHN NM, O'Donnell MA, Efstathiou JA, Zahurak M, et al
    A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.
    Eur Urol. 2023 Jan 28:S0302-2838(23)00025-8. doi: 10.1016/j.eururo.2023.
    PubMed         Abstract available

  30. PRADERE B, Basile G, Seisen T
    Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjot, Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a
    Eur Urol. 2023 Jan 28:S0302-2838(23)00024-6. doi: 10.1016/j.eururo.2022.

  31. PAOLO G, Francesco S
    Re: Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
    Eur Urol. 2023 Jan 27:S0302-2838(23)00014-3. doi: 10.1016/j.eururo.2023.

    Front Chem

  32. WANG Q, Li B, Zhang W, Li Z, et al
    Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells.
    Front Chem. 2023;11:1121724.
    PubMed         Abstract available

    Front Immunol

  33. LIU T, Li S, Xia C, Xu D, et al
    TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.
    Front Immunol. 2023;13:1071390.
    PubMed         Abstract available

    Front Oncol

  34. WANG C, Jin W, Ma X, Dong Z, et al
    The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia.
    Front Oncol. 2023;12:1101830.
    PubMed         Abstract available

  35. WANG W, Huang G, Lin H, Ren L, et al
    Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
    Front Oncol. 2023;12:1102392.
    PubMed         Abstract available

  36. LI Q, Luo Y, Liu D, Li B, et al
    Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm.
    Front Oncol. 2023;12:966506.
    PubMed         Abstract available

  37. WU K, Jiang D, Zhang L, Jiang S, et al
    Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial.
    Front Oncol. 2023;12:1065735.
    PubMed         Abstract available

    Front Surg

  38. CHEN T, Shi S, Zheng P, Zhan X, et al
    Predictive nomograms for early death in metastatic bladder cancer.
    Front Surg. 2023;9:1037203.
    PubMed         Abstract available

    Hum Cell

  39. JIANG S, Zhang J, Fan Q, Li Z, et al
    A prognostic cuproptosis-related lncRNA predictive signature for bladder cancer patients.
    Hum Cell. 2023 Jan 29. doi: 10.1007/s13577-023-00863.
    PubMed         Abstract available

  40. CHEN W, Tan M, Yu C, Liao G, et al
    ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via beta-catenin signaling and enhances mitomycin C sensitivity.
    Hum Cell. 2023 Jan 30. doi: 10.1007/s13577-023-00860.
    PubMed         Abstract available

    Int J Urol

  41. KATAYAMA S, Pradere B, Grossman NC, Potretzke AM, et al
    Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
    Int J Urol. 2023;30:63-69.
    PubMed         Abstract available

    J Gastrointest Cancer

  42. AGGARWAL A, Goel S, Sayed AI, Goel V, et al
    Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease?
    J Gastrointest Cancer. 2023 Feb 2. doi: 10.1007/s12029-023-00914.
    PubMed         Abstract available

    J Immunother Cancer

  43. Correction: Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    J Immunother Cancer. 2023;11:e005518corr1.

    J Inflamm Res

  44. DING L, Deng X, Wang K, Xia W, et al
    Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer.
    J Inflamm Res. 2023;16:283-296.
    PubMed         Abstract available

    J Oncol

  45. DONG S, Zheng L, Jiang T
    Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell Line.
    J Oncol. 2023;2023:2830306.
    PubMed         Abstract available

    Med Sci Monit

  46. WU D, Lin J, Zhu Y, Zhang H, et al
    Retracted: Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Med Sci Monit. 2023;29:e939596.
    PubMed         Abstract available

    Med Sci Sports Exerc

  47. TAAFFE DR, McCombie SP, Galvao DA, Newton RU, et al
    Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy.
    Med Sci Sports Exerc. 2023 Feb 2. doi: 10.1249/MSS.0000000000003137.
    PubMed         Abstract available

    Prog Urol

  48. AUDENET F, Neuzillet Y, Roupret M
    [Photodynamic-guided transurethral resection: Uncertainties brought to light].
    Prog Urol. 2023;33:56-57.
    PubMed         Abstract available

    Protein Pept Lett

  49. QIU M, Yu L, Liang J, Xia J, et al
    Aloperine Prevents Migration, Invasion, and Adhesion by Upregulating TIMP-4 in Human Bladder Cancer Cells.
    Protein Pept Lett. 2023 Jan 24. doi: 10.2174/0929866530666230124112754.
    PubMed         Abstract available

    Rep Biochem Mol Biol

  50. ZAHIRI E, Ghorbani H, Moradi A, Mehrad-Majd H, et al
    Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer.
    Rep Biochem Mol Biol. 2022;11:411-420.
    PubMed         Abstract available

    Sci Rep

  51. KATLEBA KD, Tsamouri MM, Jathal M, Baek HB, et al
    Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells.
    Sci Rep. 2023;13:1762.
    PubMed         Abstract available

    Stem Cell Res Ther

  52. ZHANG Y, Zhang X, Huang X, Tang X, et al
    Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Stem Cell Res Ther. 2023;14:15.
    PubMed         Abstract available

    Urol Oncol

  53. PATEL SA, Liu Y, Solanki AA, Baumann BC, et al
    Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
    Urol Oncol. 2023 Jan 30:S1078-1439(22)00494.
    PubMed         Abstract available

    Zhonghua Zhong Liu Za Zhi

  54. JING S, Feng Y, He XL, Wang Y, et al
    [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].
    Zhonghua Zhong Liu Za Zhi. 2023;45:56-63.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.